MRNA vs PANW
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 14, 2026
MRNA
PANW
Investment Advisor Scores
PANW
AI Analyst Insights
Detailed Metrics Comparison
| Metric | MRNA | PANW | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 23.0415 | 79.3651 | MRNA |
| PEG Ratio | 0 | 1.6884 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 2.1% | 34.5% | PANW |
| Earnings Growth | -85.1% | 60.5% | PANW |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 42.8/100 | 51.4/100 | PANW |
| Profit Margin | -141.4% | 2.7% | PANW |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
MRNA
MarkupPrice above SMA50, rising 50-day trend (49.6% over 20 days), RSI 64
PANW
MarkupPrice above SMA50, rising 50-day trend (4.9% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | MRNA | PANW |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | -41.0 | 183.5 |
| Trailing P/E | — | 1049.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.3% |
| Gross Margin | -0.7% | 0.7% |
| Operating Margin | -5.6% | 0.1% |
| EPS | -7.36 | 0.40 |
| Dividend Yield | — | — |